Hap Trading, LLC Intra Cellular Therapies, Inc. Put Options Transaction History

Hap Trading, LLC

  • $840 Billion
  • Q2 2024

Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 13, 2024
BUY
$64.37 - $75.65 $2.25 Million - $2.65 Million
35,000 New
35,000 $118 Million
Q3 2021

Nov 10, 2021
BUY
$28.72 - $42.49 $373,360 - $552,370
13,000 Added 87.84%
27,800 $121,000
Q2 2021

Aug 11, 2021
BUY
$29.3 - $44.5 $433,640 - $658,600
14,800 New
14,800 $40,000
Q1 2021

May 14, 2021
SELL
$30.8 - $39.51 $1.67 Million - $2.14 Million
-54,200 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$23.34 - $32.22 $214,728 - $296,424
-9,200 Reduced 14.51%
54,200 $20,000
Q3 2020

Nov 13, 2020
SELL
$17.61 - $31.86 $4.56 Million - $8.24 Million
-258,700 Reduced 80.32%
63,400 $274,000
Q2 2020

Aug 10, 2020
SELL
$14.35 - $26.64 $32.1 Million - $59.6 Million
-2,237,400 Reduced 87.42%
322,100 $640,000
Q4 2019

Feb 11, 2020
BUY
$7.26 - $38.49 $6.13 Million - $32.5 Million
843,800 Added 49.18%
2,559,500 $22,000
Q3 2019

Nov 12, 2019
BUY
$7.47 - $14.03 $11.6 Million - $21.7 Million
1,546,600 Added 914.61%
1,715,700 $716,000
Q2 2019

Aug 14, 2019
BUY
$10.65 - $14.29 $1.8 Million - $2.42 Million
169,100 New
169,100 $73,000
Q4 2017

Feb 09, 2018
SELL
$14.27 - $16.79 $722,062 - $849,574
-50,600 Closed
0 $0
Q3 2017

Nov 08, 2017
BUY
$10.77 - $22.1 $544,962 - $1.12 Million
50,600
50,600 $102,000

Others Institutions Holding ITCI

# of Institutions
398
Shares Held
87.5M
Call Options Held
309K
Put Options Held
302K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.07B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email